Maysa Abu-khalaf, MD
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · Thomas Jefferson University · Yale University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Maysa Abu-khalaf, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:53 UTC. Open this list on ClinicalTrials.gov
- N/ANCT05327608 · Time Restricted Eating for the Improvement of Outcomes in Patients With Stage I-III Breast Cancer Receiving Chemotherapy Before SurgeryThomas Jefferson University · recruiting · Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 · principal investigator
- Ph1NCT03955640 · Hyperthermia and Olaparib in Treating Breast Cancer Patients With Chest Wall RecurrencesThomas Jefferson University · terminated · Metastatic Malignant Neoplasm in the Chest Wall, Recurrent Breast Carcinoma · principal investigator
- Ph1/Ph2NCT01938833 · Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast CancerSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · terminated · HER2-negative Breast Cancer, Inflammatory Breast Cancer, Male Breast Cancer · principal investigator
- Ph2NCT00411788 · A Phase II Study of Rapamycin and Trastuzumab for Patients With HER-2 Receptor Positive Metastatic Breast CancerYale University · completed · Breast Cancer · principal investigator
- Ph2NCT00002679 · Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast CancerYale University · completed · Breast Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:53 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in breast cancer, ranked by citations from NIH iCite, fetched 2026-11-12 12:53 UTC. The ranking covers the 200 most relevant of 1 PubMed records, and a shared surname and initials can bring in a namesake. All 1 on PubMed
- 42 citationsRCR 8.5